HEALIOS K.K.
Clinical-stage biotech developing regenerative medicine and cell-based therapies.
4593 | T
Overview
Corporate Details
- ISIN(s):
- JP3835100003
- LEI:
- Country:
- Japan
- Address:
- 千代田区有楽町一丁目７番１号
- Website:
- https://www.healios.co.jp/en/
Description
Healios K.K. is a clinical-stage biotechnology company specializing in the research and development of regenerative medicine and cell-based therapies. The company's pipeline is focused on addressing unmet medical needs in multiple therapeutic areas. Its lead programs include an allogeneic stem cell product in late-stage clinical development for ischemic stroke and Acute Respiratory Distress Syndrome (ARDS). Healios also leverages its proprietary induced pluripotent stem cell (iPSC) platform to develop next-generation treatments. This platform includes retinal pigment epithelium (RPE) cells for age-related macular degeneration and engineered natural killer (eNK) cells designed to target solid tumors. A key area of its research is the creation of Universal Donor Cells (UDCs) to produce hypoimmunogenic therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-08-14 08:04 |
四半期報告書－第13期第2四半期(2023/04/01－2023/06/30)
|
Japanese | 416.7 KB | ||
| 2023-05-12 08:19 |
確認書
|
Japanese | 8.4 KB | ||
| 2023-05-12 08:18 |
四半期報告書－第13期第1四半期(2023/01/01－2023/03/31)
|
Japanese | 331.7 KB | ||
| 2023-03-29 08:22 |
確認書
|
Japanese | 8.3 KB | ||
| 2023-03-29 08:22 |
内部統制報告書－第12期(2022/01/01－2022/12/31)
|
Japanese | 22.1 KB | ||
| 2023-03-29 08:21 |
有価証券報告書－第12期(2022/01/01－2022/12/31)
|
Japanese | 1.2 MB | ||
| 2022-11-14 07:04 |
確認書
|
Japanese | 8.3 KB | ||
| 2022-11-14 07:03 |
四半期報告書－第12期第3四半期(令和4年7月1日－令和4年9月30日)
|
Japanese | 375.0 KB | ||
| 2022-08-09 08:08 |
確認書
|
Japanese | 8.2 KB | ||
| 2022-08-09 08:07 |
四半期報告書－第12期第2四半期(令和4年4月1日－令和4年6月30日)
|
Japanese | 360.4 KB | ||
| 2022-05-10 08:07 |
四半期報告書－第12期第1四半期(令和4年1月1日－令和4年3月31日)
|
Japanese | 303.0 KB | ||
| 2022-03-28 08:16 |
確認書
|
Japanese | 8.2 KB | ||
| 2022-03-28 08:15 |
有価証券報告書－第11期(令和3年1月1日－令和3年12月31日)
|
Japanese | 1.2 MB | ||
| 2022-03-28 08:15 |
内部統制報告書－第11期(令和3年1月1日－令和3年12月31日)
|
Japanese | 21.8 KB | ||
| 2021-11-12 07:41 |
四半期報告書－第11期第3四半期(令和3年7月1日－令和3年9月30日)
|
Japanese | 349.9 KB |
Automate Your Workflow. Get a real-time feed of all HEALIOS K.K. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for HEALIOS K.K.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HEALIOS K.K. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
